Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Titre croissant(e)) Affiner la rechercheArticle
J. Hérault ; A. Gérard ; A. Carnicer ; D. Aloi ; M.-L. Peyrichon ; C. Barnel ; M. Vidal ; G. Angellier ; D. Fayaud ; J.-C. Grini ; A. Giusto ; C. Armando ; G. Donadey ; M. Cabannes ; S. Dumas ; Y. Payan ; J.-F. Di Carlo ; C. Salicis ; J.-M. Bergerot ; M. Rolion ; R. Trimaud ; P. Hofverberg ; P. Mandrillon ; W. Sauerwein ; J. Thariat |Purpose Radiotherapy with protons (PT) is a standard treatment of ocular tumors. It achieves excellent tumor control, limited toxicities, and the preservation of important functional outcomes, such as vision. Although PT may appear as one homoge[...]Article
C. Le Péchoux ; C. Llacer ; P. Sargos ; L. Moureau-Zabotto ; A. Ducassou ; M.-P. Sunyach ; M.-C. Biston ; J. Thariat |We present the update of the recommendations of the French society of radiation oncology on soft tissue sarcomas. Currently, the initial management of sarcomas is very important as it may impact on patients’ quality of life, especially in limb s[...]Article
M. Césaire ; A. Rambeau ; François Cherifi ; B. Géry ; A. Johnson ; M. Nacher ; J. Thariat |Purpose : Radiotherapy induces significant and prolonged lymphopenia in head and neck cancer patients with poorer outcomes and reduced survival. Irradiated volumes may be correlated with lymphopenia with a potential impact on immunotherapy effic[...]Article
T. Leleu ; V. Bastit ; M. Doré ; E. Kammerer ; Carmen Florescu ; M. Alfonsi ; I. Troussier ; R.-J. Bensadoun ; J. Biau ; E. Blais ; A. Coutté ; M. Deberne ; N. Wiazzane ; C. Dupin ; J.-C. Faivre ; P. Giraud ; P. Graff ; S. Guihard ; F. Huguet ; G. Janoray ; X. Liem ; Yoann Pointreau ; S. Racadot ; U. Schick ; S. Servagi-Vernat ; X.S. Sun ; S. Thureau ; J. Villa ; N. Vulquin ; S. Wong ; V. Patron ; J. Thariat |Purpose : Endoscopic endonasal surgery (EES) is becoming a standard for most malignant sinonasal tumours. Margin analysis after piecemeal resection is complex and optimally relies on accurate histosurgical mapping. Postoperative radiotherapy may[...]Article
X.S. Sun ; J. Le Guevelou ; J. Jacquemin ; Y. Drouet ; T.S. Sio ; G. Bar-Sela ; C. Carrie ; J.-C. Faivre ; J. Khalifa ; C. Demiroz ; H. Qiu ; U. Schick ; B. Atalar ; N. Fakhry ; L. Mengue ; J. Pan ; S. Servagi-Vernat ; J. Thariat |Purpose Anaplastic thyroid carcinomas (ATC) are a heterogenous group of tumors of overall dismal prognosis. We designed models to identify relevant prognostic factors of survival of irradiated ATC patients including radiotherapy modalities (fiel[...]Article
A. Gérard ; M.-L. Peyrichon ; M. Vidal ; C. Barnel ; W. Sauerwein ; A. Carnicer ; G. Angellier ; T.M. Mathis ; K.K. Mishra ; J. Thariat ; J. Hérault |Purpose In radiotherapy, the dose and volumes of the irradiated normal tissues is correlated to the complication rate. We assessed the performances of low-energy proton therapy (ocular PT) with eye-dedicated equipment, high energy PT with pencil[...]Article
N. Khalladi ; C. Dejean ; M. Bosset ; Yoann Pointreau ; R. Kinj ; S. Racadot ; J. Castelli ; F. Huguet ; S. Renard ; S. Guihard ; Y. Tao ; J.M. Rouvier ; A. Johnson ; J. Bourhis ; S. Xu Shan ; J. Thariat |/Purpose A Benchmark Case (BC) was performed as part of the quality assurance process of the randomized phase 2 GORTEC 2014-14 OMET study, testing the possibility of multisite stereotactic radiation therapy (SBRT) alone in oligometastatic head[...]Article
Yoann Pointreau ; J. Biau ; N. Delaby ; J. Thariat ; M. Lapeyre |We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy for hypopharynx. Intensity-modulated radiotherapy is the gold standard treatment for hypopharynx cancers. Early T1 and T2 tumors could[...]Article
M. Lapeyre ; S. Racadot ; S. Renard ; J. Biau ; J.F. Moreira ; M.-C. Biston ; Yoann Pointreau ; J. Thariat ; P. Graff-Cailleaud |Intensity modulated radiation therapy and brachytherapy are standard techniques of irradiation for the treatment of oral cavity cancers. These techniques are detailed in terms of indication, planning, delineation and selection of the volumes of [...]Article
A. Larnaudie ; P.-Y. Marcy ; N. Delaby ; V. Costes-Martineau ; I. Troussier ; R.-J. Bensadoun ; S. Vergez ; S. Servagi-Vernat ; J. Thariat |Primary tumours of the salivary glands account for about 5 to 10% of tumours of the head and neck. These tumours represent a multitude of situations and histologies, where surgery is the mainstay of treatment and radiotherapy is frequently neede[...]Article
A. Larnaudie ; N. Delaby ; P.-Y. Marcy ; T. Leleu ; V. Costes-Martineau ; S. Vergez ; L. de Gabory ; J.-C. Quintyn ; M. Doré ; Yoann Pointreau ; J. Thariat |We present the update of the recommendations of the French society of radiotherapy and oncology on the indications and the technical methods of carrying out radiotherapy of sinonasal cancers. Sinonasal cancers (nasal fossae and sinus) account fo[...]Article
Cyrus Chargari ; A. Escande ; P. Dupuis ; J. Thariat |Reirradiation of a tumor recurrence or second cancer in a previously irradiated area is challenging due to lack of high-quality physical, radiobiological, clinical data and inherent substantial risks of toxicity with cumulative dose and uncertai[...]Article
C. Gilli ; J. Thariat ; S. Chacun ; A.M. Nguyen ; O. Loria ; L. Kodjikian ; T. Mathis |La rétinopathie radique est une pathologie vasculaire occlusive faisant suite à une radiothérapie, généralement dirigée sur l’œil ou sur des structures péri-oculaires. Malgré des techniques de plus en plus précises (radiothérapie stéréotaxique, [...]Article
Purpose OsteoRadioNecrosis (ORN) is a late complication of radiation for head and neck cancer. Predicting ORN is a major challenge. We developed DERO (Dosimetric Evaluation of Risk of ORN), a semi-automatic tool which reports doses delivered to [...]
